Simcere Pharmaceutical Group Limited (HKG:2096)
Hong Kong · Delayed Price · Currency is HKD 14.28
+1.28 (9.85%)
Jul 29, 2025, 4:08 PM HKT
HKG:2096 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 733.17 | 714.76 | 930.87 | 1,507 | 669.53 |
Depreciation & Amortization | 300.79 | 291.51 | 268.66 | 234.39 | 204.97 |
Other Amortization | 36.86 | 18.09 | 14.99 | 17.42 | 17.36 |
Loss (Gain) From Sale of Assets | 1.5 | -791.92 | 10.57 | -402.02 | 1.81 |
Asset Writedown & Restructuring Costs | - | 28.47 | - | - | - |
Loss (Gain) From Sale of Investments | 266.25 | 744.82 | -113.11 | -697.19 | -473.9 |
Loss (Gain) on Equity Investments | -2.16 | -7.84 | -0.19 | 44.19 | 14.27 |
Stock-Based Compensation | 97.81 | 12.12 | 138.29 | 62.39 | 32.8 |
Provision & Write-off of Bad Debts | -6.84 | -0.87 | -13.97 | 15.83 | 6.74 |
Other Operating Activities | 49.3 | 62.68 | 38.36 | -182.36 | 186.04 |
Change in Accounts Receivable | -94.47 | -322.9 | 86.24 | -545.2 | -542.15 |
Change in Inventory | -24.83 | -376.64 | -116.99 | -8.33 | -35.46 |
Change in Accounts Payable | - | - | - | 81.87 | -13.23 |
Change in Unearned Revenue | -15.43 | -10.24 | -14.26 | -30.34 | 5.93 |
Change in Other Net Operating Assets | 49.18 | -210.99 | 124.65 | -299.73 | 22.04 |
Operating Cash Flow | 1,391 | 151.05 | 1,354 | -201.97 | 96.73 |
Operating Cash Flow Growth | 820.98% | -88.84% | - | - | -87.48% |
Capital Expenditures | -356.97 | -483.18 | -342.82 | -209.49 | -352.84 |
Sale of Property, Plant & Equipment | 50.09 | 118.31 | 0.27 | 5.91 | 0.94 |
Cash Acquisitions | - | - | - | - | 1.76 |
Divestitures | 34.11 | 993.52 | - | 97.7 | - |
Sale (Purchase) of Intangibles | -405.6 | -496.67 | -335.19 | - | - |
Investment in Securities | -502.98 | 793.29 | 479.5 | -1,091 | 779.21 |
Other Investing Activities | 131.26 | 162.54 | 266.54 | 761.71 | 100.02 |
Investing Cash Flow | -1,050 | 1,088 | 68.31 | -435.5 | 529.08 |
Short-Term Debt Issued | - | - | - | - | 35.51 |
Long-Term Debt Issued | 1,253 | 1,216 | 916.93 | 1,027 | 2,057 |
Total Debt Issued | 1,253 | 1,216 | 916.93 | 1,027 | 2,092 |
Short-Term Debt Repaid | - | - | - | - | -35.51 |
Long-Term Debt Repaid | -1,505 | -1,367 | -1,233 | -2,505 | -1,827 |
Total Debt Repaid | -1,505 | -1,367 | -1,233 | -2,505 | -1,862 |
Net Debt Issued (Repaid) | -252.13 | -151.07 | -316.38 | -1,478 | 229.77 |
Issuance of Common Stock | - | - | - | - | 3,120 |
Repurchase of Common Stock | -687.99 | -289.07 | - | - | - |
Common Dividends Paid | -401.48 | -419.22 | -391.3 | -391.3 | - |
Other Financing Activities | 934.19 | -35.47 | -46.01 | 244.75 | -996.11 |
Financing Cash Flow | -407.4 | -894.83 | -753.68 | -1,625 | 2,354 |
Foreign Exchange Rate Adjustments | 2.29 | 4.83 | 15.12 | -35.1 | -64 |
Net Cash Flow | -64.09 | 348.85 | 683.85 | -2,297 | 2,915 |
Free Cash Flow | 1,034 | -332.13 | 1,011 | -411.46 | -256.11 |
Free Cash Flow Margin | 15.59% | -5.03% | 15.99% | -8.23% | -5.68% |
Free Cash Flow Per Share | 0.41 | -0.13 | 0.39 | -0.16 | -0.11 |
Cash Interest Paid | 30.79 | 35.47 | 29.98 | 70.85 | 141.18 |
Cash Income Tax Paid | 114.54 | 10.18 | -7.1 | 14.7 | 154.67 |
Levered Free Cash Flow | 453.05 | -1,045 | 175.48 | 438.89 | -1,096 |
Unlevered Free Cash Flow | 496.52 | -1,023 | 196.99 | 483.17 | -1,012 |
Change in Net Working Capital | -115.33 | 809.61 | -74.09 | -232.63 | 1,289 |
Updated Sep 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.